BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32683355)

  • 21. Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia.
    Doyle JS; Scott N; Sacks-Davis R; Pedrana AE; Thompson AJ; Hellard ME;
    Aliment Pharmacol Ther; 2019 May; 49(9):1223-1229. PubMed ID: 30908706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cross-sectional study of real life data of HCV from Turkey south region.
    Suntur BM; Kaya H; Eker HBŞ; Kara B; Bozok T; Unal N
    J Infect Dev Ctries; 2020 Apr; 14(4):380-386. PubMed ID: 32379715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and management of hepatitis C patients in primary care clinics.
    Shehab TM; Orrego M; Chunduri R; Lok AS
    Am J Gastroenterol; 2003 Mar; 98(3):639-44. PubMed ID: 12650800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence and clinico-epidemiological correlates of hepatitis C viral antibodies at an antenatal booking clinic of a tertiary hospital in Nigeria.
    Okusanya BO; Aigere EO; Eigbefoh JO; Ikheloa J
    Arch Gynecol Obstet; 2013 Sep; 288(3):495-500. PubMed ID: 23455542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing Efficient Systems through Electronic Medical Records to Promote Intra-hospital Referrals of Hepatitis Virus Carriers to Hepatology Specialists: A Multicenter Questionnaire-based Survey of 1,281 Healthcare Professionals.
    Hidaka I; Enomoto M; Sato S; Suetsugu A; Matono T; Ito K; Ogawa K; Inoue J; Horino M; Kondo Y; Sakaida I; Korenaga M
    Intern Med; 2021; 60(3):337-343. PubMed ID: 33518608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study.
    Litwin AH; Drolet M; Nwankwo C; Torrens M; Kastelic A; Walcher S; Somaini L; Mulvihill E; Ertl J; Grebely J
    J Viral Hepat; 2019 Sep; 26(9):1094-1104. PubMed ID: 31074167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
    Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
    Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [National study of screening practices for hepatitis C among hemodialysis patients. Hepatitis Group].
    Ducret N; Mercier S; Colin C; Vergnon P; Laroche C; Bailly F; Caillette A; Labeeuw M; Trepo C
    Nephrologie; 1998; 19(4):217-22. PubMed ID: 9675762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B and C seroprevalence among health care workers in a tertiary hospital in Rwanda.
    Kateera F; Walker TD; Mutesa L; Mutabazi V; Musabeyesu E; Mukabatsinda C; Bihizimana P; Kyamanywa P; Karenzi B; Orikiiriza JT
    Trans R Soc Trop Med Hyg; 2015 Mar; 109(3):203-8. PubMed ID: 25636951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C management by addiction medicine physicians: results from a national survey.
    Litwin AH; Kunins HV; Berg KM; Federman AD; Heavner KK; Gourevitch MN; Arnsten JH
    J Subst Abuse Treat; 2007 Jul; 33(1):99-105. PubMed ID: 17379472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoting notification and linkage of HBs antigen and anti-HCV antibody-positive patients through hospital alert system.
    Yoshioka N; Okumura A; Yamamoto Y; Yamaguchi K; Kaga A; Yamada K; Hirosaki T; Ishikawa D; Kunii S; Watanabe K; Utsunomiya S; Hayashi K; Ishigami M; Goto H; Hirooka Y
    BMC Infect Dis; 2017 May; 17(1):330. PubMed ID: 28482818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program.
    Kåberg M; Hammarberg A; Lidman C; Weiland O
    Infect Dis (Lond); 2017 Oct; 49(10):728-736. PubMed ID: 28574295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance.
    Pallarés C; Carvalho-Gomes Â; Hontangas V; Conde I; Di Maira T; Aguilera V; Benlloch S; Berenguer M; López-Labrador FX
    J Clin Virol; 2018 May; 102():77-83. PubMed ID: 29525634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of hepatitis C patients by primary care physicians in the USA: results of a national survey.
    Shehab TM; Sonnad SS; Lok AS
    J Viral Hepat; 2001 Sep; 8(5):377-83. PubMed ID: 11555196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of intervention in hepatitis C patients and improvement in their referral rate.
    Ying JQ; Zhang YJ; Xia YQ; Ma HD; Zhang T; Tu L; Zheng AH; Gao P; Wang WH
    Ann Med; 2024 Dec; 56(1):2346537. PubMed ID: 38696817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre.
    Islam MM; Topp L; Conigrave KM; White A; Reid SE; Grummett S; Haber PS; Day CA
    J Subst Abuse Treat; 2012 Dec; 43(4):440-5. PubMed ID: 22938915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens.
    Irving WL; Smith S; Cater R; Pugh S; Neal KR; Coupland CA; Ryder SD; Thomson BJ; Pringle M; Bicknell M; Hippisley-Cox J
    J Viral Hepat; 2006 Apr; 13(4):264-71. PubMed ID: 16611193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes and costs of single-step hepatitis C testing in primary care, Birmingham, United Kingdom.
    Munang M; Smit E; Barnett T; Atherton C; Tahir M; Atabani SF
    Public Health; 2019 Jan; 166():40-44. PubMed ID: 30448691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatitis C in Germany: an analysis of statutory sickness funds claims data].
    Tomeczkowski J; Cornberg M
    Dtsch Med Wochenschr; 2015 Apr; 140(8):e67-73. PubMed ID: 25945914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.